Back to all Representative Matters
Jan 31, 2017

Mettrum Health Corp. Completes Cannabis Sector Sale to Canopy Growth Corporation

Margaret T. Nelligan and John D. Andrew

Mettrum Health Corp., a leading producer and vendor of medical cannabis, announced the successful closing of the acquisition of Mettrum by Canopy Growth Corporation pursuant to the terms of an arrangement agreement. Under the arrangement, Canopy acquired all of the issued and outstanding common shares of Mettrum, and Mettrum’s shareholders became entitled to receive 0.7132 common shares of Canopy.

As a result of the acquisition, Mettrum has become a wholly-owned subsidiary of Canopy, trading of Mettrum shares has been halted and, in the normal course, Mettrum’s shares will no longer be listed on the TSX Venture Exchange.

With three licenses to produce and sell medical cannabis under the Access to Cannabis for Medical Purposes Regulations, Mettrum is a leading producer and vendor of medical cannabis. In addition, through its wholly-owned subsidiary Mettrum Hempworks, Mettrum is also a licensed producer and distributor of industrial cannabis (hemp) products, including Mettrum's functional food line, Mettrum Originals™, under the Industrial Hemp Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada).

Aird & Berlis LLP represented the special committee of Mettrum’s board of directors in connection with the sale, with a team comprised of Margaret Nelligan and Daniel Everall (Corporate Governance and Securities) and John Andrew (Corporate).

Related Industries

Related Representative Matters

Representative Matters
Nextleaf Solutions Ltd. Completes Acquisition of Licensed Processor Melanie Cole, Alicia McKeag, Barbara Worndl and Saam Nainifard Aug 04, 2020 Nextleaf Solutions Ltd., an innovative Canadian cannabis extractor, recently completed the acquis... Nextleaf Solutions Ltd., an innovative Canadian cannabis extractor, recently completed the acquisition of all of the issued and outstanding shares of Nextleaf Labs Ltd., a company that holds Health Canada standard processing and research licenses under the Cannabis Act (Canada).
Representative Matters
MediPharm Labs Completes $37.8 Million Private Placement Melanie Cole, Amy Marcen-Gaudaur, Meredith McCann and Aaron Collins Jun 22, 2020 MediPharm Labs Corp., a global leader in specialized, research-driven pharmaceutical-quality cann... MediPharm Labs Corp., a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, recently completed a private placement with an institutional investor for aggregate gross proceeds of $37,822,500.
Representative Matters
Champignon Brands Completes $15 Million Bought Deal Private Placement Jeffrey K. Merk, Melanie Cole, Russell J. Sanders and Francesco Gucciardo Jun 11, 2020 Aird & Berlis advised Champignon Brands Inc., a ketamine clinic operator, psychedelic medicine IP... Aird & Berlis advised Champignon Brands Inc., a ketamine clinic operator, psychedelic medicine IP aggregator and novel drug discoverer, in connection with its $15 million bought deal private placement.